Light-based imaging of green fluorescent protein-positive ovarian cancer xenografts during therapy

Tandra R. Chaudhuri, James M. Mountz, Buck E. Rogers, Edward E. Partridge, Kurt R. Zinn

Research output: Contribution to journalArticle

40 Scopus citations

Abstract

Objective. The purpose of the study was to develop a sensitive, noninvasive imaging method for monitoring ovarian xenografts during therapeutic intervention. Methods. Human ovarian tumor cells (SKOV3.ip1) were infected with a replication-deficient adenoviral (Ad) vector encoding green fluorescent protein (GFP). The GFP-positive tumor cells were imaged in vitro and in viva with a fluorescence stereomicroscope. Using appropriate filters, both GFP fluorescence and adriamycin were simultaneously detected. Nude mice implanted with GFP-positive cells were imaged repeatedly, in a noninvasive manner. Results. SKOV3.ip1 cells infected with Ad-GFP showed high GFP fluorescence, which was eliminated after treatment with adriamycin. Loss of GFP fluorescence was confirmed to be dead cells. For in viva imaging, intraperitoneal tumors as small as 0.2 mm in diameter were detected externally. Adriamycin uptake was detected in tumors by in viva imaging, and reduction in tumor size was concurrent with decrease in GFP fluorescence. These findings were confirmed at necropsy. Conclusions. Fluorescence stereomicroscopy monitored the response of ovarian xenografts to adriamycin therapy. For the first time, GFP and adriamycin were imaged simultaneously,

Original languageEnglish
Pages (from-to)581-589
Number of pages9
JournalGynecologic oncology
Volume82
Issue number3
DOIs
StatePublished - Jan 1 2001
Externally publishedYes

Keywords

  • Adriamycin
  • Green fluorescent protein
  • Imaging
  • Ovarian cancer

Fingerprint Dive into the research topics of 'Light-based imaging of green fluorescent protein-positive ovarian cancer xenografts during therapy'. Together they form a unique fingerprint.

  • Cite this